Many synthetic cannabinoids were designed by Pfizer in the 1970s and 1980s, and feature an alphanumeric code beginning with the prefix "CP" (after Charles Pfizer).[1] Recently, several members of this class of cannabinoids have been discovered in recreational drug products.[2][3][4]
- CP 47,497 —
- (C6)-CP 47,497 —
- (C7)-CP 47,497 (CP 47,497 itself) —
- (C8)-CP 47,497 (Cannabicyclohexanol) —
- (C9)-CP 47,497 —
- CP 50,556-1 (Levonantradol) —
- CP 55,244 —
- CP 55,940 —
- (±)-CP 55,940 — (±)-CP 55,940 is a widely used cannabinoid research tool.[5][6]
- (+)-CP 55,940 —
- (-)-CP 55,940 —
- CP-945,598 (Otenabant) —
See also
References
- ↑ "Details for Synthetic cannabinoids". www.unodc.org. Retrieved 2025-04-26.
- ↑ Adams, Axel J.; Banister, Samuel D.; Irizarry, Lisandro; Trecki, Jordan; Schwartz, Michael; Gerona, Roy (2017-01-19). ""Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York". New England Journal of Medicine. 376 (3): 235–242. doi:10.1056/NEJMoa1610300. ISSN 0028-4793.
- ↑ "How Pfizer Helped Make Fake Pot". The Daily Beast. 2014-05-17. Retrieved 2025-04-26.
- ↑ Maia, J.; Fonseca, B. M.; Teixeira, N.; Correia-da-Silva, G. (2023-09-01). "Unveiling the angiogenic effects of cannabinoids: Enhancers or inhibitors?". Biochemical Pharmacology. 215 115686. doi:10.1016/j.bcp.2023.115686. hdl:10216/164995. ISSN 0006-2952.
- ↑ "CP 55,940". localhost. Retrieved 2025-04-26.
- ↑ Huffman, John W.; Thompson, Alicia L. S.; Wiley, Jenny L.; Martin, Billy R. (2008-01-01). "Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940". Bioorganic & Medicinal Chemistry. Nucleic Acid Modification for Fluroescence-Based Technologies. 16 (1): 322–335. doi:10.1016/j.bmc.2007.09.033. ISSN 0968-0896. PMC 2262798. PMID 17919913.